The mutations were concordant between the primary and metastatic carcinomas in all, except for the ERBB2 case, where the primary carcinoma had the mutation, while the corresponding metastasis showed no detectable mutations, possibly due to sampling bias or tumor heterogeneity. The gene discussed is ERBB2; the disease is carcinoma.